Investor mix
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 86% |
| Private equity | 1 | 14% |
Developer of oncolytic immunotherapeutics for the treatment of cancer
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 86% |
| Private equity | 1 | 14% |